AR and prostate cancer: When AR-positive human prostate carcinoma LNCaP cell line was compared to PC-3 and DU145 AR-negative prostate cancer cell lines, the inhibitory action of FK506 on cell growth was evidenced only in the AR-positive cells when they were treated with steroid [90].